ENZO BIOCHEM, INC. Deferred Offering Costs
ENZO BIOCHEM, INC. had Deferred Offering Costs of $30.00 million as of 2024-01-31, per its 10-Q filed 2024-03-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-03-13
- 2024-01-31: Deferred Offering Costs $30.00M.
- 2023-10-31: Deferred Offering Costs $30.00M.
- 2023-07-31: Deferred Offering Costs $30.00M.
- 2023-04-30: Deferred Offering Costs $30.00M.
| Period end | Deferred Offering Costs |
|---|---|
| 2024-01-31 | $30.00M 10-Q · filed 2024-03-13 |
| 2023-10-31 | $30.00M 10-Q · filed 2023-12-15 |
| 2023-07-31 | $30.00M 10-K · filed 2023-11-03 |
| 2023-04-30 | $30.00M 10-Q · filed 2023-06-14 |